We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
+$77M
Cap. Flow %
2.17%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNA icon
401
PUT
Moderna
MRNA
$21.5B
$237K 0.01%
+28,000
New +$3.54M
SPY icon
402
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$227K 0.01%
+100,000
New +$52.3M
OVID icon
403
Ovid Therapeutics
OVID
$495M
$222K 0.01%
288,290
+28,790
+11% +$80.1K
QTTB icon
404
Q32 Bio
QTTB
$482M
$215K 0.01%
+12,000
New +$287K
NFE icon
405
PUT
New Fortress Energy
NFE
$98M
$187K 0.01%
+51,100
New +$1.32M
NBR icon
406
PUT
Nabors Industries
NBR
$1.23B
$185K 0.01%
19,100
HOG icon
407
PUT
Harley-Davidson
HOG
$2.67B
$178K 0.01%
100,000
SVRA icon
408
Savara
SVRA
$1.19B
$177K 0.01%
43,978
-43,459
-50% -$193K
XME icon
409
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$4.22B
$152K ﹤0.01%
+104,900
New +$6.42M
OMF icon
410
PUT
OneMain Financial
OMF
$7.48B
$132K ﹤0.01%
30,500
VRDN icon
411
Viridian Therapeutics
VRDN
$2.55B
$131K ﹤0.01%
10,057
-6,400
-39% -$88.6K
IMUX icon
412
Immunic
IMUX
$198M
$131K ﹤0.01%
11,769
-5,000
-30% -$62.1K
SYF icon
413
PUT
Synchrony
SYF
$25.6B
$124K ﹤0.01%
+21,900
New +$951K
EVLVW
414
DELISTED
Evolv Technologies Warrant
EVLVW
$122K ﹤0.01%
478,241
DTIL icon
415
Precision BioSciences
DTIL
$205M
$112K ﹤0.01%
11,546
CCL icon
416
PUT
Carnival Corporation Ltd
CCL
$39.4B
$107K ﹤0.01%
771,500
VNO icon
417
PUT
Vornado Realty Trust
VNO
$7.27B
$107K ﹤0.01%
+33,500
New +$857K
FE icon
418
PUT
FirstEnergy
FE
$27.4B
$105K ﹤0.01%
+26,000
New +$1.01M
VKTX icon
419
CALL
Viking Therapeutics
VKTX
$3.88B
$102K ﹤0.01%
13,600
-36,400
-73% -$2.39M
IONS icon
420
CALL
Ionis Pharmaceuticals
IONS
$9.06B
$98.1K ﹤0.01%
18,000
-2,000
-10% -$82K
UBX
421
DELISTED
Unity Biotechnology
UBX
$97.2K ﹤0.01%
71,983
+1,586
+2% +$2.41K
IMCR icon
422
PUT
Immunocore
IMCR
$1.75B
$94.5K ﹤0.01%
+30,000
New +$1.53M
NVO
423
CALL
Novo Nordisk
NVO
$203B
$90.1K ﹤0.01%
35,000
-10,000
-22% -$1.33M
CCOI icon
424
PUT
Cogent Communications
CCOI
$546M
$90K ﹤0.01%
+17,300
New +$1.03M
CYH icon
425
CALL
Community Health Systems
CYH
$416M
$88.1K ﹤0.01%
525,000

Similar funds

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.